{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T16:06:04Z","timestamp":1793462764534,"version":"4.5.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2017,9,10]],"date-time":"2017-09-10T00:00:00Z","timestamp":1505001600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Japan Society for the Promotion of Science (JP)","award":["Grant-in-aid for Scientific Research (C) 23591237"],"award-info":[{"award-number":["Grant-in-aid for Scientific Research (C) 23591237"]}]},{"name":"the Amyloidosis Research Committee, the Ministry of Health, Labour and Welfare, Japan"},{"name":"Pfizer, Inc.","award":["2015 Global ASPIRE TTR-FAP Competitive Research Grant Award"],"award-info":[{"award-number":["2015 Global ASPIRE TTR-FAP Competitive Research Grant Award"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1007\/s00259-017-3814-1","type":"journal-article","created":{"date-parts":[[2017,9,11]],"date-time":"2017-09-11T09:52:07Z","timestamp":1505123527000},"page":"452-461","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":62,"title":["Visualization of multiple organ amyloid involvement in systemic amyloidosis using 11C-PiB PET imaging"],"prefix":"10.1007","volume":"45","author":[{"given":"Naoki","family":"Ezawa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6993-0607","authenticated-orcid":false,"given":"Nagaaki","family":"Katoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhiro","family":"Oguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsuneaki","family":"Yoshinaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahide","family":"Yazaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiki","family":"Sekijima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,9,10]]},"reference":[{"key":"3814_CR1","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1007\/s00259-012-2237-2","volume":"40","author":"A Nordberg","year":"2013","unstructured":"Nordberg A, Carter SF, Rinne J, Drzezga A, Brooks DJ, Vandenberghe R, et al. A European multicentre PET study of fibrillar amyloid in Alzheimer's disease. Eur J Nucl Med Mol Imaging. 2013;40:104\u201314. \nhttps:\/\/doi.org\/10.1007\/s00259-012-2237-2\n\n.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"3814_CR2","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1002\/ana.21164","volume":"62","author":"KA Johnson","year":"2007","unstructured":"Johnson KA, Gregas M, Becker JA, Kinnecom C, Salat DH, Moran EK, et al. Imaging of amyloid burden and distribution in cerebral amyloid angiopathy. Ann Neurol. 2007;62:229\u201334. \nhttps:\/\/doi.org\/10.1002\/ana.21164\n\n.","journal-title":"Ann Neurol"},{"key":"3814_CR3","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/S0076-6879(99)09020-5","volume":"309","author":"H LeVine III","year":"1999","unstructured":"LeVine H III. Quantification of beta-sheet amyloid fibril structures with thioflavin T. Methods Enzymol. 1999;309:274\u201384.","journal-title":"Methods Enzymol"},{"key":"3814_CR4","doi-asserted-by":"publisher","first-page":"213","DOI":"10.2967\/jnumed.111.102053","volume":"54","author":"G Antoni","year":"2013","unstructured":"Antoni G, Lubberink M, Estrada S, Axelsson J, Carlson K, Lindsjo L, et al. In vivo visualization of amyloid deposits in the heart with 11C-PIB and PET. J Nucl Med. 2013;54:213\u201320. \nhttps:\/\/doi.org\/10.2967\/jnumed.111.102053\n\n.","journal-title":"J Nucl Med"},{"key":"3814_CR5","doi-asserted-by":"publisher","first-page":"21","DOI":"10.3109\/13506129.2013.860895","volume":"21","author":"E Hellstrom-Lindahl","year":"2014","unstructured":"Hellstrom-Lindahl E, Westermark P, Antoni G, Estrada S. In vitro binding of [3H]PIB to human amyloid deposits of different types. Amyloid. 2014;21:21\u20137. \nhttps:\/\/doi.org\/10.3109\/13506129.2013.860895\n\n.","journal-title":"Amyloid"},{"key":"3814_CR6","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1212\/wnl.0000000000003001","volume":"87","author":"Y Sekijima","year":"2016","unstructured":"Sekijima Y, Yazaki M, Oguchi K, Ezawa N, Yoshinaga T, Yamada M, et al. Cerebral amyloid angiopathy in posttransplant patients with hereditary ATTR amyloidosis. Neurology. 2016;87:773\u201381. \nhttps:\/\/doi.org\/10.1212\/wnl.0000000000003001\n\n.","journal-title":"Neurology"},{"key":"3814_CR7","doi-asserted-by":"publisher","unstructured":"Gertz MA, Comenzo R, Falk RH, Fermand JP, Hazenberg BP, Hawkins PN, et al. Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): a consensus opinion from the 10th International Symposium on Amyloid and Amyloidosis, Tours, France, 18-22 April 2004, 18-22 April 2004. Am J Hematol. 2005;79:319\u201328. \nhttps:\/\/doi.org\/10.1002\/ajh.20381\n\n.","DOI":"10.1002\/ajh.20381"},{"key":"3814_CR8","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.1016\/j.humpath.2011.03.004","volume":"42","author":"Y Sekijima","year":"2011","unstructured":"Sekijima Y, Uchiyama S, Tojo K, Sano K, Shimizu Y, Imaeda T, et al. High prevalence of wild-type transthyretin deposition in patients with idiopathic carpal tunnel syndrome: a common cause of carpal tunnel syndrome in the elderly. Hum Pathol. 2011;42:1785\u201391. \nhttps:\/\/doi.org\/10.1016\/j.humpath.2011.03.004\n\n.","journal-title":"Hum Pathol"},{"key":"3814_CR9","first-page":"128","volume":"48","author":"NM Scheinin","year":"2007","unstructured":"Scheinin NM, Tolvanen TK, Wilson IA, Arponen EM, Nagren KA, Rinne JO. Biodistribution and radiation dosimetry of the amyloid imaging agent 11C-PIB in humans. J Nucl Med. 2007;48:128\u201333.","journal-title":"J Nucl Med"},{"key":"3814_CR10","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1056\/nejm199008233230803","volume":"323","author":"PN Hawkins","year":"1990","unstructured":"Hawkins PN, Lavender JP, Pepys MB. Evaluation of systemic amyloidosis by scintigraphy with 123I-labeled serum amyloid P component. N Engl J Med. 1990;323:508\u201313. \nhttps:\/\/doi.org\/10.1056\/nejm199008233230803\n\n.","journal-title":"N Engl J Med"},{"key":"3814_CR11","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1007\/s002590050273","volume":"25","author":"A Rydh","year":"1998","unstructured":"Rydh A, Suhr O, Hietala SO, Ahlstrom KR, Pepys MB, Hawkins PN. Serum amyloid P component scintigraphy in familial amyloid polyneuropathy: regression of visceral amyloid following liver transplantation. Eur J Nucl Med. 1998;25:709\u201313.","journal-title":"Eur J Nucl Med"},{"key":"3814_CR12","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/0140-6736(91)90478-8","volume":"338","author":"SR Nelson","year":"1991","unstructured":"Nelson SR, Hawkins PN, Richardson S, Lavender JP, Sethi D, Gower PE, et al. Imaging of haemodialysis-associated amyloidosis with 123I-serum amyloid P component. Lancet. 1991;338:335\u20139.","journal-title":"Lancet"},{"key":"3814_CR13","doi-asserted-by":"publisher","first-page":"1978","DOI":"10.1016\/j.ajpath.2011.06.024","volume":"179","author":"D Rowczenio","year":"2011","unstructured":"Rowczenio D, Dogan A, Theis JD, Vrana JA, Lachmann HJ, Wechalekar AD, et al. Amyloidogenicity and clinical phenotype associated with five novel mutations in apolipoprotein A-I. Am J Pathol. 2011;179:1978\u201387. \nhttps:\/\/doi.org\/10.1016\/j.ajpath.2011.06.024\n\n.","journal-title":"Am J Pathol"},{"key":"3814_CR14","doi-asserted-by":"publisher","first-page":"134","DOI":"10.3109\/13506129.2016.1158160","volume":"23","author":"DF Hutt","year":"2016","unstructured":"Hutt DF, Gilbertson J, Quigley AM, Wechalekar AD. (99m)Tc-DPD scintigraphy as a novel imaging modality for identification of skeletal muscle amyloid deposition in light-chain amyloidosis. Amyloid. 2016;23:134\u20135. \nhttps:\/\/doi.org\/10.3109\/13506129.2016.1158160\n\n.","journal-title":"Amyloid"},{"key":"3814_CR15","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1007\/s00259-001-0730-0","volume":"29","author":"M Puille","year":"2002","unstructured":"Puille M, Altland K, Linke RP, Steen-Muller MK, Kiett R, Steiner D, et al. 99mTc-DPD scintigraphy in transthyretin-related familial amyloidotic polyneuropathy. Eur J Nucl Med Mol Imaging. 2002;29:376\u20139.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"3814_CR16","doi-asserted-by":"publisher","first-page":"48","DOI":"10.3109\/13506129.2012.746938","volume":"20","author":"CC Quarta","year":"2013","unstructured":"Quarta CC, Obici L, Guidalotti PL, Pieroni M, Longhi S, Perlini S, et al. High 99mTc-DPD myocardial uptake in a patient with apolipoprotein AI-related amyloidotic cardiomyopathy. Amyloid. 2013;20:48\u201351. \nhttps:\/\/doi.org\/10.3109\/13506129.2012.746938\n\n.","journal-title":"Amyloid"},{"key":"3814_CR17","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/BF00253162","volume":"6","author":"BK Rao","year":"1981","unstructured":"Rao BK, Padmalatha C, Au Buchon J, Lieberman LM. Hepatic and splenic scintigraphy in idiopathic systemic amyloidosis. Eur J Nucl Med. 1981;6:143\u20136.","journal-title":"Eur J Nucl Med"},{"key":"3814_CR18","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1007\/BF00998166","volume":"16","author":"S Janssen","year":"1990","unstructured":"Janssen S, Piers DA, van Rijswijk MH, Meijer S, Mandema E. Soft-tissue uptake of 99mTc-diphosphonate and 99mTc-pyrophosphate in amyloidosis. Eur J Nucl Med. 1990;16:663\u201370.","journal-title":"Eur J Nucl Med"},{"key":"3814_CR19","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1161\/circimaging.112.000132","volume":"6","author":"S Bokhari","year":"2013","unstructured":"Bokhari S, Castano A, Pozniakoff T, Deslisle S, Latif F, Maurer MS. (99m)Tc-pyrophosphate scintigraphy for differentiating light-chain cardiac amyloidosis from the transthyretin-related familial and senile cardiac amyloidoses. Circ Cardiovasc Imaging. 2013;6:195\u2013201. \nhttps:\/\/doi.org\/10.1161\/circimaging.112.000132\n\n.","journal-title":"Circ Cardiovasc Imaging"},{"key":"3814_CR20","doi-asserted-by":"publisher","first-page":"58","DOI":"10.3109\/13506129.2015.1135792","volume":"23","author":"M Nakagawa","year":"2016","unstructured":"Nakagawa M, Sekijima Y, Yazaki M, Tojo K, Yoshinaga T, Doden T, et al. Carpal tunnel syndrome: a common initial symptom of systemic wild-type ATTR (ATTRwt) amyloidosis. Amyloid. 2016;23:58\u201363. \nhttps:\/\/doi.org\/10.3109\/13506129.2015.1135792\n\n.","journal-title":"Amyloid"},{"key":"3814_CR21","doi-asserted-by":"publisher","first-page":"1652","DOI":"10.1007\/s00259-014-2787-6","volume":"41","author":"S Dorbala","year":"2014","unstructured":"Dorbala S, Vangala D, Semer J, Strader C, Bruyere JR Jr, Di Carli MF, et al. Imaging cardiac amyloidosis: a pilot study using 18F-florbetapir positron emission tomography. Eur J Nucl Med Mol Imaging. 2014;41:1652\u201362. \nhttps:\/\/doi.org\/10.1007\/s00259-014-2787-6\n\n.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"3814_CR22","doi-asserted-by":"publisher","first-page":"23","DOI":"10.3389\/fcvm.2015.00023","volume":"2","author":"DR Osborne","year":"2015","unstructured":"Osborne DR, Acuff SN, Stuckey A, Wall JS. A routine PET\/CT protocol with streamlined calculations for assessing cardiac amyloidosis using (18)F-florbetapir. Front Cardiovasc Med. 2015;2:23. \nhttps:\/\/doi.org\/10.3389\/fcvm.2015.00023\n\n.","journal-title":"Front Cardiovasc Med"},{"key":"3814_CR23","doi-asserted-by":"publisher","first-page":"e115","DOI":"10.1097\/rlu.0000000000000947","volume":"41","author":"SM Broski","year":"2016","unstructured":"Broski SM, Spinner RJ, Howe BM, Dispenzieri A, Johnson GB. 18F-Florbetapir and 18F-FDG PET\/CT in systemic immunoglobulin light chain amyloidosis involving the peripheral nerves. Clin Nucl Med. 2016;41:e115\u20137. \nhttps:\/\/doi.org\/10.1097\/rlu.0000000000000947\n\n.","journal-title":"Clin Nucl Med"},{"key":"3814_CR24","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.remn.2016.03.006","volume":"36","author":"P Garc\u00eda-Gonz\u00e1lez","year":"2017","unstructured":"Garc\u00eda-Gonz\u00e1lez P, S\u00e1nchez-Jurado R, Cozar-Santiago MP, Ferrando-Beltr\u00e1n M, P\u00e9rez-Rodriguez PL, Ferrer-Rebolleda J. Laryngeal and cardiac amyloidosis diagnosed by 18F-Florbetapir PET\/CT. Rev Esp Med Nucl Imagen Mol. 2017;36:135\u20136. \nhttps:\/\/doi.org\/10.1016\/j.remn.2016.03.006\n\n.","journal-title":"Rev Esp Med Nucl Imagen Mol"},{"key":"3814_CR25","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1111\/bjh.14519","volume":"177","author":"N Leung","year":"2017","unstructured":"Leung N, Ramirez-Alvarado M, Nasr SH, Kemp BJ, Johnson GB. Detection of ALECT2 amyloidosis by positron emission tomography-computed tomography imaging with florbetapir. Br J Haematol. 2017;177:12. \nhttps:\/\/doi.org\/10.1111\/bjh.14519\n\n.","journal-title":"Br J Haematol"},{"key":"3814_CR26","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1097\/rlu.0000000000001434","volume":"42","author":"E D'Estanque","year":"2017","unstructured":"D'Estanque E, Chambert B, Moranne O, Kotzki PO, Boudousq V. 18F-Florbetaben: a new tool for amyloidosis staging? Clin Nucl Med. 2017;42:50\u20133. \nhttps:\/\/doi.org\/10.1097\/rlu.0000000000001434\n\n.","journal-title":"Clin Nucl Med"},{"key":"3814_CR27","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1007\/BF01791147","volume":"22","author":"C Aprile","year":"1995","unstructured":"Aprile C, Marinone G, Saponaro R, Bonino C, Merlini G. Cardiac and pleuropulmonary AL amyloid imaging with technetium-99m labelled aprotinin. Eur J Nucl Med. 1995;22:1393\u2013401.","journal-title":"Eur J Nucl Med"},{"key":"3814_CR28","first-page":"177","volume":"44","author":"BK Schaadt","year":"2003","unstructured":"Schaadt BK, Hendel HW, Gimsing P, Jonsson V, Pedersen H, Hesse B. 99mTc-aprotinin scintigraphy in amyloidosis. J Nucl Med. 2003;44:177\u201383.","journal-title":"J Nucl Med"},{"key":"3814_CR29","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1007\/BF01254559","volume":"22","author":"PN Hawkins","year":"1995","unstructured":"Hawkins PN, Pepys MB. Imaging amyloidosis with radiolabelled SAP. Eur J Nucl Med. 1995;22:595\u20139.","journal-title":"Eur J Nucl Med"},{"key":"3814_CR30","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1007\/s12350-013-9803-2","volume":"21","author":"S Bokhari","year":"2014","unstructured":"Bokhari S, Shahzad R, Castano A, Maurer MS. Nuclear imaging modalities for cardiac amyloidosis. J Nucl Cardiol. 2014;21:175\u201384. \nhttps:\/\/doi.org\/10.1007\/s12350-013-9803-2\n\n.","journal-title":"J Nucl Cardiol"},{"key":"3814_CR31","first-page":"419","volume":"3","author":"T Ohyama","year":"1990","unstructured":"Ohyama T, Shimokama T, Yoshikawa Y, Watanabe T. Splenic amyloidosis: correlations between chemical types of amyloid protein and morphological features. Mod Pathol. 1990;3:419\u201322.","journal-title":"Mod Pathol"},{"key":"3814_CR32","doi-asserted-by":"publisher","first-page":"282405","DOI":"10.1155\/2015\/282405","volume":"2015","author":"AC Martins","year":"2015","unstructured":"Martins AC, Rosa AM, Costa E, Tavares C, Quadrado MJ, Murta JN. Ocular manifestations and therapeutic options in patients with familial amyloid polyneuropathy: a systematic review. Biomed Res Int. 2015;2015:282405. \nhttps:\/\/doi.org\/10.1155\/2015\/282405\n\n.","journal-title":"Biomed Res Int"},{"key":"3814_CR33","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1002\/art.1780360518","volume":"36","author":"E Hachulla","year":"1993","unstructured":"Hachulla E, Janin A, Flipo RM, Saile R, Facon T, Bataille D, et al. Labial salivary gland biopsy is a reliable test for the diagnosis of primary and secondary amyloidosis. A prospective clinical and immunohistologic study in 59 patients. Arthritis Rheum. 1993;36:691\u20137.","journal-title":"Arthritis Rheum"},{"key":"3814_CR34","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1007\/s10072-016-2760-1","volume":"38","author":"EF Paula de","year":"2017","unstructured":"de Paula EF, de Mello BL, de Carvalho DL, Della-Guardia B, de Almeida MD, Marins LV, et al. Minor salivary gland biopsy for the diagnosis of familial amyloid polyneuropathy. Neurol Sci. 2017;38:311\u20138. \nhttps:\/\/doi.org\/10.1007\/s10072-016-2760-1\n\n.","journal-title":"Neurol Sci"},{"issue":"Suppl 1","key":"3814_CR35","doi-asserted-by":"publisher","first-page":"S16","DOI":"10.1016\/j.ijsu.2008.12.025","volume":"6","author":"F Villa","year":"2008","unstructured":"Villa F, Dionigi G, Tanda ML, Rovera F, Boni L. Amyloid goiter. Int J Surg. 2008;6(Suppl 1):S16\u20138. \nhttps:\/\/doi.org\/10.1016\/j.ijsu.2008.12.025\n\n.","journal-title":"Int J Surg"},{"key":"3814_CR36","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1080\/13506120802006047","volume":"15","author":"M Matsuda","year":"2008","unstructured":"Matsuda M, Gono T, Shimojima Y, Yoshida T, Katoh N, Hoshii Y, et al. AL amyloidosis manifesting as systemic lymphadenopathy. Amyloid. 2008;15:117\u201324. \nhttps:\/\/doi.org\/10.1080\/13506120802006047\n\n.","journal-title":"Amyloid"},{"key":"3814_CR37","first-page":"45","volume":"32","author":"RA Kyle","year":"1995","unstructured":"Kyle RA, Gertz MA. Primary systemic amyloidosis: clinical and laboratory features in 474 cases. Semin Hematol. 1995;32:45\u201359.","journal-title":"Semin Hematol"},{"key":"3814_CR38","doi-asserted-by":"crossref","first-page":"403","DOI":"10.2169\/internalmedicine.53.0898","volume":"53","author":"M Matsuda","year":"2014","unstructured":"Matsuda M, Katoh N, Ikeda S. Clinical manifestations at diagnosis in Japanese patients with systemic AL amyloidosis: a retrospective study of 202 cases with a special attention to uncommon symptoms. Intern Med. 2014;53:403\u201312.","journal-title":"Intern Med"}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00259-017-3814-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-017-3814-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-017-3814-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,1,26]],"date-time":"2018-01-26T23:54:34Z","timestamp":1517010874000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00259-017-3814-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9,10]]},"references-count":38,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,3]]}},"alternative-id":["3814"],"URL":"https:\/\/doi.org\/10.1007\/s00259-017-3814-1","relation":{},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"value":"1619-7070","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,9,10]]}}}